CN101239161A - Chinese herbal medicine oral liquid formulations for treating women's Qi stagnation and blood stasis type hysteromyoma - Google Patents
Chinese herbal medicine oral liquid formulations for treating women's Qi stagnation and blood stasis type hysteromyoma Download PDFInfo
- Publication number
- CN101239161A CN101239161A CNA2008100864925A CN200810086492A CN101239161A CN 101239161 A CN101239161 A CN 101239161A CN A2008100864925 A CNA2008100864925 A CN A2008100864925A CN 200810086492 A CN200810086492 A CN 200810086492A CN 101239161 A CN101239161 A CN 101239161A
- Authority
- CN
- China
- Prior art keywords
- oral liquid
- chinese herbal
- herbal medicine
- stagnation
- blood stasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a oral Chinese traditional medicine liquid preparation for treating woman qi stagnation and blood stasis type hysteromyoma, which is prepared from 14 Chinese traditional medicines including white snake tongue grass, danshen root, santsigu tuber, prepared cyperus rotundus l, danbianjiuzhu, dandelion. The oral liquid preparation has advantages and merits of easy confection, convenient in use, simple processing technology, precious target, strong guiding force, rapid effect, better treating effect, non-toxic side effect, 100% effective rate and cure rate in clinic, and has great useful value.
Description
Technical field
The purpose of this invention is to provide a kind of Chinese herbal medicine oral liquid formulations that is used for the treatment of the hysteromyoma disease.In particular for the Chinese herbal medicine oral liquid formulations of the new trouble disorder stagnation of QI and blood stasis type hysteromyoma disease, has unique curative effect.
Background technology
Hysteromyoma claims fibroma uteri again, it is generally acknowledged relevant with the dysfunction of ovarian secretion hormone.Chinese medicine is thought the scope that belongs to the Chinese medicine mass in the abdomen, is the benign tumor among the common genitals of women, is mainly formed by uterine smooth muscle cell and fibrous tissue, and great majority are multiple, and single-shot is also arranged.Hard piece arranged at intraperitoneal, firmly do not move, localized pain, push away the characteristics of not loosing of rubbing according to the new trouble disorder, clinically show as that menstrual cycle shortens, menstrual period are long, hyper-menorrhea more, and irregular metrorrhagia, and can show as anemia, symptoms such as frequent micturition, urgent micturition, constipation.The compressing of factor palace muscular tumor in addition can cause the fallopian tube position change or cause distortion, often becomes the reason of infertility.This disease pilosity is born in 30 years old later women of child-bearing age, is born in the ovarian function characteristics in comparatively vigorous stage according to this disease pilosity.This disease has two types of the stagnation of QI and blood stasis, and its disease is because of menstrual phase or puerperal, by internal injury raw food or due to having a cold outward, and internal injury caused by excess of seven emotions, depression of liver-QI, QI rising in reverse order and blood stays, or the melancholy impairing the spleen deficiency of vital energy and stasis, or form the muscular tumor disease a little less than the long-pending stasis of blood gas of long-pending consumptive disease.Be the Therapeutic Principle mainly with the broken knot of circulation of qi promoting, blood circulation promoting and blood stasis dispelling, softening the hard mass removing food stagnancy, benefiting vital QI and blood.Use a kind of Chinese herbal medicine oral liquid formulations that is used for the treatment of hysteromyoma of the present invention, good use value is arranged clinically.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese herbal medicine oral liquid formulations for the treatment of women's Qi stagnation and blood stasis type hysteromyoma disease, it can take orally separately, also can cooperate the symptomatic treatment of gynecological's hysteromyoma disease that all types of pathology causes of disease of other Chinese medicine formula determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs cause.
The proportioning of technical solution of the present invention is formed: Herba Hedyotidis Diffusae 250-300g; Radix Salviae Miltiorrhizae 200-300g; Pseudobulbus Cremastrae Seu Pleiones 120-200g; Rhizoma Corydalis 120-200g; Spina Gleditsiae 150-200g; Rhizoma Curcumae 150-200g; Rhizoma Cyperi (processed) 120-200g; Herba Taraxaci 150-200g; DANBIANJIUZHU 150-200g; Herba Leonuri 150-200g; Herba Verbenae 150-200g; SIFANGJI 120-200g; Herba Violae 150-200g; 200-300g ends May; Form Deng Chinese herbal medicine.Also can cooperate other medicines etc. in right amount, select materials through the tunnel, conventional concoct, low baking temperature oven dry roasting is dry, it is standby to be distributed into 10 parcels, or it is decocted the drug juice that co-blended after three times is condensed into 5000 milliliters, be distributed into 10 bottles, 500 milliliters every bottle, seal standby Chinese herbal medicine oral liquid formulations or make filling bag, the Chinese herbal medicine oral liquid formulations of fresh-keeping type.
A kind of hysteromyoma that is used for the treatment of of the present invention, be particularly useful for the Chinese herbal medicine oral liquid formulations of the new trouble disorder stagnation of QI and blood stasis type hysteromyoma disease, it is the clinical experience elite of having drawn traditional Traditional Chinese Medicine experts, discuss in conjunction with modern Chinese medicine gynecological, Chinese medicine and pharmacy, the science of arteries and veins opinion, simultaneously in conjunction with excavation prescription,local proved recipe, and compositing formula is the Therapeutic Principle with the broken knot of circulation of qi promoting, blood circulation promoting and blood stasis dispelling, softening the hard mass removing food stagnancy benefiting vital QI and blood.Herba Hedyotidis Diffusae in the side: eliminating inflammation and expelling toxin, muscular tumor disappears; Radix Salviae Miltiorrhizae: removing heat from blood detumescence, tissue regeneration promoting go to dislike; Pseudobulbus Cremastrae Seu Pleiones: clearing heat for detumescence, detoxifcation; Rhizoma Corydalis: promoting flow of QI and blood, eliminating stasis to stop pain; Spina Gleditsiae: detumescence and apocenosis; Rhizoma Curcumae: circulation of qi promoting, dissipating blood stasis, pain relieving; Rhizoma Cyperi (processed): the resolving depression of regulating the flow of vital energy, pain relieving regulating menstruation; Herba Taraxaci energy heat-clearing and toxic substances removing, the pain that dissipates swell; DANBIANJIUZHU: antitumor; Herba Leonuri: tissue regeneration promoting blood stasis removing; Herba Verbenae: heat-clearing and toxic substances removing; SIFANGJI: antitumor; Herba Violae: heat-clearing and toxic substances removing; End May: warming the meridian for stopping bleeding.Make a general survey of full presciption medicine and imitate just thorough pathogenesis, stable curative effect is reliable.In order to give full play to effect of the present invention, can cooperate other Chinese medicine formula plus-minus determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs during clinical practice.
Adopt Chinese herbal medicine oral liquid formulations of the present invention, the treatment stagnation of QI and blood stasis type hysteromyoma disease have the medicine preparation easily, strong, the instant effect of taking convenience, Special medicine for special disease, target spot standard, guiding force, short treating period, good effect, without any side effects.Clinical application symptomatic treatment total effective rate reaches absolutely, and cure rate reaches advantage and effects such as a hundred per cent, particularly to a medical circle difficult problem both at home and abroad now, and the treatment of hysteromyoma of gynecology disease, application technology is innovated, and adopts traditional Chinese herbal and crude drugs preparations.For effective new side's medicine of studying and inquiring into the hysteromyoma of gynecology disease of the treatment stagnation of QI and blood stasis type provides reliable scientific basis.
The specific embodiment
Embodiment is described in detail in detail below:
Method one, get Herba Hedyotidis Diffusae 250-300g; Radix Salviae Miltiorrhizae 200-300g; Pseudobulbus Cremastrae Seu Pleiones 120-200g; Rhizoma Corydalis 120-200g; Spina Gleditsiae 120-200g; Rhizoma Curcumae 150-200g; Rhizoma Cyperi (processed) 120-200g; Herba Taraxaci 150-200g; DANBIANJIUZHU 150-200g; Herba Leonuri 150-200g; Herba Verbenae 150-200g; SIFANGJI 120-200g; Herba Violae 150-200g; 200-300g ends May; Deng Chinese herbal medicine, select materials through the tunnel, conventional concoct, low baking temperature oven dry roasting is dry, be distributed into 10 parcels, every day, 1-2 wrapped (light disease person 1 bag, serious symptom person's 2 bags) get a bag Chinese herbal medicine and soak a moment with 500-600 milliliter drinking water, decoct about 30 minutes after liquid medicine is fried in shallow oil out again, the 200-300 milliliter decoction being taken warmly that takes concoction is fried in shallow oil, three is fried in shallow oil decoction being taken warmly with decoction two again after every dose of head is fried in shallow oil.
Method two, get Herba Hedyotidis Diffusae 250-300g; Radix Salviae Miltiorrhizae 200-300g; Pseudobulbus Cremastrae Seu Pleiones 120-200g; Rhizoma Corydalis 120-200g; Spina Gleditsiae 120-200g; Rhizoma Curcumae 150-200g; Rhizoma Cyperi (processed) 120-200g; Herba Taraxaci 150-200g; DANBIANJIUZHU 150-200g; Herba Leonuri 150-200g; Herba Verbenae 150-200g; SIFANGJI 120-200g; Herba Violae 150-200g; 200-300g ends May; Deng Chinese herbal medicine, select materials through the tunnel, conventional concoct, low baking temperature oven dry roasting is dry standby, each soaks a moment to add drinking water 5000-6000 milli, decoct to endure again about 30 minutes after boiling, the 200-300 milliliter that takes concoction, the same again method was carried out two frying in shallow oil, three is fried in shallow oil after head was fried in shallow oil.Take concoction altogether and mix about about 8000-9000 milliliter, be condensed into 5000 milliliters with slow fire after, cold is cold naturally, is distributed into 500 milliliters one bottle again, totally ten bottles seal standby Chinese herbal medicine oral liquid formulations.
Clinical practice Chinese herbal medicine oral liquid formulations treatment of the present invention new trouble disorder, women's Qi stagnation and blood stasis type hysteromyoma disease 23 examples, wherein 28 years old of the age minimum, oldest 51 years old, the shortest 15 days of medicine time, the longest 45 days, effective percentage absolutely, cure rate absolutely, this is to a current medical science difficult problem both at home and abroad, the utilization innovation of women's Qi stagnation blood stasis type hysteromyoma disease treatment technology provides reliable scientific basis for inquiring into the effective new side's medicine of development.
Claims (2)
1. Chinese herbal medicine oral liquid formulations that is used for the treatment of women's Qi stagnation and blood stasis type hysteromyoma is characterized in that it is made up of following proportioning component: Herba Hedyotidis Diffusae, Radix Salviae Miltiorrhizae, Pseudobulbus Cremastrae Seu Pleiones, Rhizoma Corydalis, Spina Gleditsiae, Rhizoma Curcumae, Rhizoma Cyperi (processed), Herba Taraxaci, DANBIANJIUZHU, Herba Leonuri, Herba Verbenae, SIFANGJI, Herba Violae, May, Chinese herbal medicine such as Chinese mugwort was formed.
2. claims 1 described Chinese herbal medicine oral liquid formulations that is used for the treatment of women's Qi stagnation and blood stasis type hysteromyoma, it is characterized in that being that it can be distributed into 10 parcels packages spare, or after it is decocted filtration, be condensed into oral liquid filling bottle dress or irritate bag, be packaged into fresh-keeping type oral liquid formulations.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008100864925A CN101239161A (en) | 2008-03-13 | 2008-03-13 | Chinese herbal medicine oral liquid formulations for treating women's Qi stagnation and blood stasis type hysteromyoma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008100864925A CN101239161A (en) | 2008-03-13 | 2008-03-13 | Chinese herbal medicine oral liquid formulations for treating women's Qi stagnation and blood stasis type hysteromyoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101239161A true CN101239161A (en) | 2008-08-13 |
Family
ID=39931170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2008100864925A Pending CN101239161A (en) | 2008-03-13 | 2008-03-13 | Chinese herbal medicine oral liquid formulations for treating women's Qi stagnation and blood stasis type hysteromyoma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101239161A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102908582A (en) * | 2012-09-18 | 2013-02-06 | 康莉 | Traditional Chinese medicine composition for treating blood stasis type abdominal mass for women and preparation method thereof |
| CN106074790A (en) * | 2016-06-29 | 2016-11-09 | 邱定武 | A kind of medical herbs for oral administration treating qi stagnation and blood stasis type lumbago and using method thereof |
-
2008
- 2008-03-13 CN CNA2008100864925A patent/CN101239161A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102908582A (en) * | 2012-09-18 | 2013-02-06 | 康莉 | Traditional Chinese medicine composition for treating blood stasis type abdominal mass for women and preparation method thereof |
| CN106074790A (en) * | 2016-06-29 | 2016-11-09 | 邱定武 | A kind of medical herbs for oral administration treating qi stagnation and blood stasis type lumbago and using method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102370725B (en) | A kind of compound Chinese medicinal preparation treating chronic pelvic inflammatory disease and preparation method thereof | |
| CN103071023B (en) | Traditional Chinese medicinal composition for effectively treating diabetes | |
| CN105169214A (en) | Traditional Chinese medicine composition for treating atherosclerosis, and preparation method thereof | |
| CN103393989B (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN104258289A (en) | Traditional Chinese medicine for treating enteritis | |
| CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN102416145B (en) | Chinese medicinal composition for treating menstrual disorder | |
| CN101637576B (en) | Traditional Chinese medicine for treating nephritis | |
| CN101239161A (en) | Chinese herbal medicine oral liquid formulations for treating women's Qi stagnation and blood stasis type hysteromyoma | |
| CN101234184B (en) | Orally-administered Chinese medicine composition for treating radiation proctitis | |
| CN105816802A (en) | Orally-taken traditional Chinese medicine preparation for treating wind heat-type common cold | |
| CN104887893B (en) | A kind of external application Chinese medicine and application method for treating gynaecology's dysmenorrhoea disease | |
| CN103989803A (en) | Traditional Chinese medicine for treating infertility | |
| CN104707090A (en) | Chinese herbal formula for treating coronary heart disease | |
| CN105535367A (en) | Traditional Chinese medicine for treating kidney-deficiency type hypomenorrhea | |
| CN102327524A (en) | Traditional Chinese medicine composition for curing erysipelas | |
| CN101926954B (en) | Clysis decoction for treating chronic colitis | |
| CN101301441A (en) | Formulation of Chinese herbal medicine oral liquid and cold tea for treating recurrent mouth ulcer | |
| CN105213831A (en) | A kind of Chinese medicine composition for the treatment of epidemic hemorrhagic fever | |
| CN105663408A (en) | Decoction medicine for treating abnormal menstruation and insufficient menstrual blood volume as well as preparation method thereof | |
| CN104644956A (en) | Traditional Chinese medicine composition for treating cold congealing and blood stasis type dysmenorrheal and preparation method thereof | |
| CN104013836A (en) | Traditional Chinese medicine composition for treating sequela of cerebral apoplexy | |
| CN103599388B (en) | The Chinese medicine decoction for the treatment of dysfunctional uterine bleeding | |
| CN104189615B (en) | Traditional Chinese medicine preparation for treating metrorrhagia and metrostaxis, and preparation method of traditional Chinese medicine preparation | |
| CN101700297B (en) | Medicine for treating hemorrhoids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| DD01 | Delivery of document by public notice |
Addressee: Zhang Xuming Document name: Notification that Application Deemed to be Withdrawn |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20080813 |